GSK signs AI pact with Ochre to pinpoint source of liver disease
12 Jun 2024 //
FIERCE BIOTECH
Ochre Bio, Boehringer Partner On Liver Disease Treatments
22 Apr 2024 //
BUSINESSWIRE
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors
16 May 2023 //
BUSINESSWIRE
Ochre Bio Strengthens Leadership Team with Liver Disease Translational Expertise
05 Apr 2023 //
BUSINESSWIRE
Ochre Bio Announces Participation in Upcoming Conferences
31 Oct 2022 //
BUSINESSWIRE
Ochre Bio Announces Formation of Scientific Strategy Board
20 Oct 2022 //
BUSINESSWIRE
Ochre Raises $30M Series A Financing for the Development of RNA Therapies
10 Oct 2022 //
BUSINESSWIRE
Ochre Bio Launches ‘Liver ICU’ in the United States
11 May 2022 //
BUSINESSWIRE